Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism GRK2 inhibitors(G protein-coupled receptor kinase 2 inhibitors), IGF-1 inhibitors(Insulin-like growth factor I inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H32N8O3S |
InChIKeyYNSCKPCDFIDINW-UHFFFAOYSA-N |
CAS Registry1123163-20-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Failure | Preclinical | United States | 03 Oct 2014 |